Literature DB >> 9032804

Inhibin, activin and follistatin in the human placenta--a new family of regulatory proteins.

F Petraglia1.   

Abstract

The family of inhibin-related proteins has been investigated extensively in the last decade. It is composed of three members: inhibin, activin and follistatin. Inhibin and activin are chemically related, while follistatin acts as an activin-binding protein. Initially identified as regulators of pituitary follice stimulating hormone (FSH) secretion, inhibin, activin and follistatin have more recently been characterized as growth factors, embryo modulators and immune factors. Human placenta, amnion, chorion and maternal decidua express mRNAs for inhibin, activin and follistatin, and the presence of both immunoreactive and bioactive proteins has been demonstrated. The proteins are present in maternal and fetal circulation, and are measurable in amniotic fluid with changes related to gestational age and to the occurrence of gestational diseases. Various biological actions have been described in embryo and intrauterine tissues, which suggest a role for these proteins in the development of the gestational unit. However, several questions remain to be elucidated. The chemical forms of inhibin, activin and follistatin produced by human placenta and the mechanisms involved in the regulation of their secretion are largely unknown. The nature of the receptors for these proteins and the physiological implications of receptor activation have not yet been elucidated and this will require further investigation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032804     DOI: 10.1016/s0143-4004(97)90065-5

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  5 in total

Review 1.  Human Perinatal-Derived Biomaterials.

Authors:  Marc C Moore; Aurore Van De Walle; Jerry Chang; Cassandra Juran; Peter S McFetridge
Journal:  Adv Healthc Mater       Date:  2017-08-07       Impact factor: 9.933

2.  Immunohistochemical Analysis of E-Cadherin, p53 and Inhibin-α Expression in Hydatidiform Mole and Hydropic Abortion.

Authors:  Onur Erol; Dinç Süren; Birsel Tutuş; Tayfun Toptaş; Ahmet Arda Gökay; Aysel Uysal Derbent; Mustafa Kemal Özel; Cem Sezer
Journal:  Pathol Oncol Res       Date:  2015-12-18       Impact factor: 3.201

3.  Circulating profile of Activin-Follistatin-Inhibin Axis in women with hypothalamic amenorrhea in response to leptin treatment.

Authors:  Eirini Bouzoni; Nikolaos Perakakis; Christos S Mantzoros
Journal:  Metabolism       Date:  2020-10-10       Impact factor: 8.694

4.  Inhibin/activin subunits alpha, beta-A and beta-B are differentially expressed in normal human endometrium throughout the menstrual cycle.

Authors:  Ioannis Mylonas; Udo Jeschke; Irmgard Wiest; Anna Hoeing; Julia Vogl; Naim Shabani; Christina Kuhn; Sandra Schulze; Markus S Kupka; Klaus Friese
Journal:  Histochem Cell Biol       Date:  2004-10-12       Impact factor: 4.304

5.  Placental secretome characterization identifies candidates for pregnancy complications.

Authors:  Tina Napso; Xiaohui Zhao; Marta Ibañez Lligoña; Ionel Sandovici; Richard G Kay; Amy L George; Fiona M Gribble; Frank Reimann; Claire L Meek; Russell S Hamilton; Amanda N Sferruzzi-Perri
Journal:  Commun Biol       Date:  2021-06-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.